Pain phenotypes classified by machine learning using electroencephalography features.

Journal: NeuroImage
Published Date:

Abstract

Pain is a multidimensional experience mediated by distributed neural networks in the brain. To study this phenomenon, EEGs were collected from 20 subjects with chronic lumbar radiculopathy, 20 age and gender matched healthy subjects, and 17 subjects with chronic lumbar pain scheduled to receive an implanted spinal cord stimulator. Analysis of power spectral density, coherence, and phase-amplitude coupling using conventional statistics showed that there were no significant differences between the radiculopathy and control groups after correcting for multiple comparisons. However, analysis of transient spectral events showed that there were differences between these two groups in terms of the number, power, and frequency-span of events in a low gamma band. Finally, we trained a binary support vector machine to classify radiculopathy versus healthy subjects, as well as a 3-way classifier for subjects in the 3 groups. Both classifiers performed significantly better than chance, indicating that EEG features contain relevant information pertaining to sensory states, and may be used to help distinguish between pain states when other clinical signs are inconclusive.

Authors

  • Joshua Levitt
    Department of Neurosurgery, Rhode Island Hospital, and Department of Neuroscience, Brown University, Providence, RI, USA; Department of Neuroscience, Brown University, Providence, RI, USA.
  • Muhammad M Edhi
    Department of Neurosurgery, Rhode Island Hospital, Providence, RI, United States.
  • Ryan V Thorpe
    Department of Neuroscience, Brown University, Providence, RI, United States.
  • Jason W Leung
    Department of Neurosurgery, Rhode Island Hospital, Providence, RI, United States.
  • Mai Michishita
    Laboratory for Pharmacology, Asahi Kasei Pharma Corporation, Mifuku, Shizuoka, Japan.
  • Suguru Koyama
    Department of Neurosurgery, Rhode Island Hospital, and Department of Neuroscience, Brown University, Providence, RI, USA; Department of Neuroscience, Brown University, Providence, RI, USA; Laboratory for Pharmacology, Asahi KASEI Pharma Corporation, Shizuoka, Japan.
  • Satoru Yoshikawa
    Laboratory for Pharmacology, Asahi Kasei Pharma Corporation, Mifuku, Shizuoka, Japan.
  • Keith A Scarfo
    Department of Neurosurgery, Rhode Island Hospital, Providence, RI, United States.
  • Alexios G Carayannopoulos
    Department of Neurosurgery, Rhode Island Hospital, Providence, RI, United States.
  • Wendy Gu
    Boston Scientific Neuromodulation, Valencia, CA, United States.
  • Kyle H Srivastava
    Boston Scientific Neuromodulation, Valencia, CA, United States.
  • Bryan A Clark
    Boston Scientific Neuromodulation, Valencia, CA, United States.
  • Rosana Esteller
    Boston Scientific Neuromodulation, Valencia, CA, United States.
  • David A Borton
    Department of Neuroscience, Brown University, Providence, RI, United States.
  • Stephanie R Jones
    Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, RI 02908, United States; Department of Neuroscience, Brown University, Providence, RI 02906, United States.
  • Carl Y Saab
    Department of Neurosurgery, Rhode Island Hospital, and Department of Neuroscience, Brown University, Providence, RI, USA; Department of Neuroscience, Brown University, Providence, RI, USA. Electronic address: Carl_Saab@Brown.edu.